New treatment option for Hemiparesis
Official title Effects and Mechanisms of Sensory Afferent Electrostimulation on Upper Limb Function in Patients With Hemiparesis
ClinicalTrials.gov ID: NCT06536634
What this study is testing
- What it's testing
- The goal for this project is to investigate the effects of a 5-week SAES therapy in addition to conventional therapy on both behavioural (sensory and motor) and neurological measures and the underlying mechanisms of treatment response. The goal of this project to investigate the effects of a 5-week SAES therapy in addition to conventional therapy.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 18
You may be able to join if
- Diagnosis of unilateral cerebral palsy/hemiparesis, following unilateral brain lesion, e.g. perinatal/childhood stroke (acquired prior to the age of...
- consistent and stable limitation of hand functions
- chronic state (time since lesion \>2 years)
- aged 6-18 years
- parental informed consent if \ 14 years
You likely can't join if
- psychiatric disease that prevents the participant form informed participation and compliance in an adequate manner/setting
- Bilateral brain lesion
- Recent Botulinum toxin-injections injections (UL, \< 6 months)
- Hand surgery on paretic hand \< 2 years
- Trauma to UL in the last year
- Medical conditions that prevent training of the UL
See the full eligibility criteria
- Diagnosis of unilateral cerebral palsy/hemiparesis, following unilateral brain lesion, e.g. perinatal/childhood stroke (acquired prior to the age of 16 years)
- consistent and stable limitation of hand functions
- chronic state (time since lesion \>2 years)
- aged 6-18 years
- parental informed consent if \ 14 years
- psychiatric disease that prevents the participant form informed participation and compliance in an adequate manner/setting
- Bilateral brain lesion
- Recent Botulinum toxin-injections injections (UL, \< 6 months)
- Hand surgery on paretic hand \< 2 years
- Trauma to UL in the last year
- Medical conditions that prevent training of the UL
- Participation in other afferent stimulation studies
- Electrical stimulation therapy in the last 6 months
- Intensive training of the UL (therapy more than 1x/week, \< 6 months) If MRI and TMS is performed, additionally:
- MRI and TMS contradictions, such as
- implanted Metal devices (e.g. braces, implant)
- implanted shunt system
- in girls and women: pregnancy
- claustrophobia
- Active epilepsy
The study team makes the final eligibility decision.
Where it's taking place
- Bern, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bern, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.